Physician profile
Charles B Sisson
NPI 1699717181
$5,617.82
in general payments reported to CMS, 2019-2025
19 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,856 · 2020: $261 · 2021: $1,114 · 2022: $205 · 2024: $22.53 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,009.89 | 2019-2022 | |
| Vertiflex, INC. | $1,601.81 | 2019 | |
| Medtronic, INC. | $943.16 | 2021 | |
| Abbott Laboratories | $317.45 | 2019-2021 | |
| Boston Scientific Corporation | $218.24 | 2020-2025 | Angiojet Ultra 5000a, Varithena Administration Pack, 2cm Peripheral Cutting Balloon |
| Spr Therapeutics, INC | $99.56 | 2019 | |
| Painteq LLC | $93.81 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $51.38 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $46.03 | 2019-2020 | |
| Tersera Therapeutics LLC | $39.77 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.52 | 2019-2020 | |
| Pfizer INC. | $33.78 | 2019 | |
| Lilly USA, LLC | $28.02 | 2020 | |
| Allergan, INC. | $26.56 | 2019 | |
| Si-Bone, INC. | $15.15 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.08 | 2020 | |
| Collegium Pharmaceutical, INC. | $14.92 | 2019 | |
| Horizon Therapeutics Plc | $12.31 | 2019 | |
| Medtronic USA, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Sisson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.